Hologic, Inc.
HOLX · NASDAQ
9/27/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $5 |
| % Growth | 1.7% | -0% | -17.1% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $3 | $2 | $2 | $3 |
| % Margin | 61% | 55.3% | 51.4% | 61.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $1 | $2 |
| % Margin | 17.4% | 21.9% | 16.6% | 33.7% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $0 | $1 |
| % Margin | 13.8% | 19.6% | 11.3% | 26.8% |
| EPS | 2.5 | 3.35 | 1.85 | 5.18 |
| % Growth | -25.4% | 81.1% | -64.3% | – |
| EPS Diluted | 2.49 | 3.32 | 1.83 | 5.13 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $2 |
| % Margin | 25% | 32.2% | 27.6% | 43.5% |